CH627190A5 - - Google Patents

Download PDF

Info

Publication number
CH627190A5
CH627190A5 CH861377A CH861377A CH627190A5 CH 627190 A5 CH627190 A5 CH 627190A5 CH 861377 A CH861377 A CH 861377A CH 861377 A CH861377 A CH 861377A CH 627190 A5 CH627190 A5 CH 627190A5
Authority
CH
Switzerland
Prior art keywords
group
general formula
alkyl group
hydrogen atom
sterol
Prior art date
Application number
CH861377A
Other languages
German (de)
English (en)
Inventor
Alfred Dr Weber
Mario Dr Kennecke
Helmut Dr Dahl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH627190A5 publication Critical patent/CH627190A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/005—Degradation of the lateral chains at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH861377A 1976-07-16 1977-07-12 CH627190A5 (US06312121-20011106-C00033.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762632677 DE2632677A1 (de) 1976-07-16 1976-07-16 Verfahren zur herstellung von androstan-17-on-derivaten und deren verwendung

Publications (1)

Publication Number Publication Date
CH627190A5 true CH627190A5 (US06312121-20011106-C00033.png) 1981-12-31

Family

ID=5983514

Family Applications (3)

Application Number Title Priority Date Filing Date
CH861377A CH627190A5 (US06312121-20011106-C00033.png) 1976-07-16 1977-07-12
CH415281A CH629222A5 (de) 1976-07-16 1981-06-23 Verfahren zur herstellung von androstan-derivaten.
CH415381A CH629503A5 (de) 1976-07-16 1981-06-23 Verfahren zur herstellung von androstan-derivaten.

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH415281A CH629222A5 (de) 1976-07-16 1981-06-23 Verfahren zur herstellung von androstan-derivaten.
CH415381A CH629503A5 (de) 1976-07-16 1981-06-23 Verfahren zur herstellung von androstan-derivaten.

Country Status (18)

Country Link
US (1) US4179336A (US06312121-20011106-C00033.png)
JP (1) JPS5315493A (US06312121-20011106-C00033.png)
AT (1) AT363196B (US06312121-20011106-C00033.png)
BE (1) BE856860A (US06312121-20011106-C00033.png)
CH (3) CH627190A5 (US06312121-20011106-C00033.png)
CS (1) CS200517B2 (US06312121-20011106-C00033.png)
DD (4) DD132439A5 (US06312121-20011106-C00033.png)
DE (1) DE2632677A1 (US06312121-20011106-C00033.png)
DK (1) DK142372C (US06312121-20011106-C00033.png)
FR (4) FR2365588A1 (US06312121-20011106-C00033.png)
GB (1) GB1585786A (US06312121-20011106-C00033.png)
HU (4) HU182790B (US06312121-20011106-C00033.png)
IE (1) IE45304B1 (US06312121-20011106-C00033.png)
IT (1) IT1077339B (US06312121-20011106-C00033.png)
NL (1) NL7706638A (US06312121-20011106-C00033.png)
SE (1) SE440779B (US06312121-20011106-C00033.png)
SU (1) SU980628A3 (US06312121-20011106-C00033.png)
YU (1) YU164277A (US06312121-20011106-C00033.png)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55148083A (en) * 1979-05-04 1980-11-18 Mitsubishi Chem Ind Ltd Microorganism
JPS55150893A (en) * 1979-05-11 1980-11-25 Mitsubishi Chem Ind Ltd Novel microorganism
JPS578794A (en) * 1980-06-17 1982-01-18 Mitsubishi Chem Ind Ltd Preparation of androstane-type steroid
US4755463A (en) * 1982-05-25 1988-07-05 Wisconsin Alumni Research Foundation Process for preparing steroids
US4444884A (en) * 1982-05-25 1984-04-24 Wisconsin Alumni Research Foundation Process for preparing steroids
JPH0512528Y2 (US06312121-20011106-C00033.png) * 1987-09-08 1993-03-31
DE69621281T2 (de) * 1995-02-28 2002-12-05 Nippon Shokubai Co., Ltd. Acryl-Säure-Derivate, Verfahren zur Herstellung von Acryl-Säure-Derivaten und Acryl-Säure-Polymere
PT2644206T (pt) * 2003-05-23 2019-07-10 Nektar Therapeutics Derivados de peg contendo duas cadeias de peg
CN102656153B (zh) * 2009-10-29 2015-02-18 延世大学校产学协力团 新型血管渗漏阻断剂
US9388210B2 (en) 2011-02-25 2016-07-12 Washington University Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
WO2013056181A1 (en) 2011-10-14 2013-04-18 Sage Therapeutics, Inc. 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
SI2935307T1 (en) 2012-12-18 2018-08-31 Washington University Non-reactive 19-alkoxy-17-substituted steroids useful in therapeutic procedures
US10202413B2 (en) 2013-02-15 2019-02-12 Washington University Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptors
US9512170B2 (en) 2013-03-01 2016-12-06 Washington University Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
US9365502B2 (en) 2013-03-11 2016-06-14 Washington University Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors
US9562026B2 (en) 2013-03-14 2017-02-07 Washington University Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors
CA2909546C (en) 2013-04-17 2019-01-22 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
KR102396328B1 (ko) 2013-04-17 2022-05-10 세이지 테라퓨틱스, 인크. 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
EP3868382A1 (en) 2013-07-19 2021-08-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
DK3488852T3 (da) 2013-08-23 2021-02-01 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser deraf
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP3206494A4 (en) 2014-10-16 2018-07-04 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
SI3206493T1 (sl) 2014-10-16 2020-10-30 Sage Therapeutics, Inc. Sestavki in metode za zdravljenje CNS motenj
PL3224269T3 (pl) 2014-11-27 2020-08-24 Sage Therapeutics, Inc. Kompozycje i sposoby leczenia zaburzeń OUN
SI3250210T1 (sl) 2015-01-26 2021-07-30 Sage Therapeutics, Inc. Sestavki in metode za zdravljenje CNS motenj
WO2016134301A2 (en) 2015-02-20 2016-08-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
WO2018013615A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
PE20230244A1 (es) 2019-05-31 2023-02-07 Sage Therapeutics Inc Esteroides neuroactivos y composiciones de estos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3451892A (en) * 1965-10-19 1969-06-24 Schering Corp Process for the preparation of steroidal compounds
NL6705450A (US06312121-20011106-C00033.png) * 1965-10-22 1968-10-21
US3684657A (en) * 1970-05-11 1972-08-15 Searle & Co Selective microbiological degradation of steroidal 17-alkyls
US3759791A (en) * 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione
US3738983A (en) * 1971-08-06 1973-06-12 Searle & Co Process for the preparation of 3-(3beta,17beta-dihydroxyandrost-5-en-17alpha-yl) propionic acid gamma-lactone
DE2534911C2 (de) * 1975-08-01 1985-04-18 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 5-Androsten-17-on-Derivaten

Also Published As

Publication number Publication date
DD136142A5 (de) 1979-06-20
FR2365588B1 (US06312121-20011106-C00033.png) 1982-06-25
DK142372B (da) 1980-10-20
JPS5315493A (en) 1978-02-13
IE45304L (en) 1978-01-16
IT1077339B (it) 1985-05-04
DD132439A5 (de) 1978-09-27
HU182789B (en) 1984-03-28
SE7708192L (sv) 1978-01-17
SE440779B (sv) 1985-08-19
JPS6117477B2 (US06312121-20011106-C00033.png) 1986-05-07
FR2372175A1 (fr) 1978-06-23
HU182790B (en) 1984-03-28
US4179336A (en) 1979-12-18
HU182681B (en) 1984-02-28
CS200517B2 (en) 1980-09-15
BE856860A (fr) 1978-01-16
FR2365588A1 (fr) 1978-04-21
NL7706638A (nl) 1978-01-18
SU980628A3 (ru) 1982-12-07
GB1585786A (en) 1981-03-11
CH629222A5 (de) 1982-04-15
FR2372174A1 (fr) 1978-06-23
DD136141A5 (de) 1979-06-20
FR2372176A1 (fr) 1978-06-23
IE45304B1 (en) 1982-07-28
DK323677A (da) 1978-01-17
ATA504677A (de) 1980-12-15
DD137235A5 (de) 1979-08-22
CH629503A5 (de) 1982-04-30
AT363196B (de) 1981-07-10
DK142372C (da) 1981-03-23
HU179344B (en) 1982-10-28
YU164277A (en) 1982-08-31
DE2632677C2 (US06312121-20011106-C00033.png) 1988-06-16
DE2632677A1 (de) 1978-01-26

Similar Documents

Publication Publication Date Title
CH627190A5 (US06312121-20011106-C00033.png)
CH622532A5 (US06312121-20011106-C00033.png)
EP0225892B1 (de) Verfahren zur herstellung von 4-androsten-3,17-dion und 1,4-androstadien-3,17-dion
DE2534911C2 (de) Verfahren zur Herstellung von 5-Androsten-17-on-Derivaten
DE2803660A1 (de) Neue in 17-position substituierte steroide der pregnanreihe, ihre herstellung und verwendung
EP0139907B1 (de) Verfahren zur Herstellung von Estran-Derivaten
DE1904544C3 (de) Verfahren zur mikrobiologischen Umwandlung von 3 ß-Hydroxy-5,6- epoxysteroiden in 6-Hydroxy-3-KetoA<·4 -Steroide
EP0496846B1 (de) Verfahren zur herstellung von 17-oxosteroiden
EP0013959B1 (de) Neue D-Homosteroide, Verfahren zu deren Herstellung und diese D-Homosteroide enthaltende Arzneimittel
DE2558090A1 (de) Verfahren zur herstellung von 4-androsten-3,17-dion-derivaten
EP0227588B1 (de) Verfahren zur Herstellung von 4-Androsten-3, 17-dion und 1,4-Androstadien-3,17-dion
CH625555A5 (US06312121-20011106-C00033.png)
AT254407B (de) Herstellung von Retrosteroiden
DE3248434A1 (de) Verfahren zur herstellung von 3,11(alpha)-dihydroxy-1,3,5(10)-oestratrien-derivaten
CS200520B2 (cs) Způsob výroby androstan-17-onových derivátů
DE2940285A1 (de) Verfahren zur herstellung von 11(alpha)-hydroxy-3-oxo-(delta)(pfeil hoch)1(pfeil hoch)(pfeil hoch),(pfeil hoch)(pfeil hoch)4(pfeil hoch)-steroiden
DE1172669B (de) Verfahren zur Herstellung von 11-oxygenierten 16ª‰-(2', 2'-Dicarboxyaethyl)-3,17-diketo-steroiden bzw. von deren 1-Dehydroderivaten
WO1992003465A1 (de) 20-METHYL-5,7-PREGNADIEN-3β,21-DIOL-DERIVATIVE
DE2919984A1 (de) 12 alpha -hydroxysteroide und deren herstellung
DE1143199B (de) Verfahren zur Herstellung von Equilin
DE1793784A1 (de) Verfahren zur herstellung optisch aktiver oestran-derivate
DE1150385B (de) Verfahren zur Herstellung von 6ª‡-Halogen-bzw. 6ª‡, 9ª‡-Dihalogen-pregnenen
DE2008819A1 (de) Spirostanderivat

Legal Events

Date Code Title Description
PL Patent ceased